Home / Themes / Cycle Short '24: Semi Equip
Cycle Short '24: Semi Equip
Last updated
Theme thesis · 3/5 sections · Tickers 6 with notes
Bull / Bear Details has the investment thesis and bull/bear points. Overview is monitoring guidance (hiring, forums, second-order trends, search keywords, Google Trends, datasets).
Bull / Bear DetailsThe current thesis on the Cycle '24 Short: Semi Equip, specifically for ASM NA, is bearish. The semiconductor equipment sector is anticipated to face challenges
Thesis
The current thesis on the Cycle '24 Short: Semi Equip, specifically for ASM NA, is bearish. The semiconductor equipment sector is anticipated to face challenges due to economic slowdowns and reduced capital expenditures by key players in the semiconductor manufacturing space. This reduction in demand is compounded by cyclical downturns and potential inventory corrections within the semiconductor industry. The market is also adjusting to a post-pandemic environment where previous supply chain disruptions have normalized, further impacting equipment sales.
Bull case
Economic slowdown and reduced capital expenditures are leading to lower demand for semiconductor equipment.
Inventory corrections in the semiconductor industry suggest an oversupply situation, reducing the need for new equipment.
Normalization of supply chains post-pandemic has lessened the urgency for rapid equipment purchases.
Bear case
Any resurgence in demand for advanced semiconductor technologies could spur investment in new equipment.
Government incentives for domestic semiconductor manufacturing could boost equipment demand.
Technological advancements and transitions to new node technologies may necessitate new equipment purchases.
Key Metrics
| Metric | Cadence | What It Signals | Update Source |
|---|---|---|---|
| Equipment Order Backlogs | Monthly | Represents demand and future sales potential | Google_Sheets |
| Semiconductor Capital Spending | Quarterly | Indicates investment levels in new equipment | Google_Sheets |
| Inventory Levels in Semiconductors | Monthly | Reflects potential oversupply or shortage | Google_Sheets |
Upcoming Catalysts
| Catalyst ID | Estimated Timing | Estimated Date Start | Estimated Date End | Catalyst | Why It Matters | Ticker Or Theme Specific | Transcript Date | Source Type | Catalyst Source |
|---|---|---|---|---|---|---|---|---|---|
| ASM.AS_c9d50771 | Continued 2-nanometer capacity expansions during 2026 | 2026-01-01 | 2026-12-31 | Customer-led 2-nanometer capacity expansion programs (including sub-nodes such as backside power distribution) planned to continue in 2026. | Stronger-than-expected 2nm capacity adds raise ALD and Epi intensity (supporting higher ASPs, volume and margins at ASM); weaker or postponed 2nm investments would reduce demand for ASM's leading-edge tools and weigh on growth and margin outlook. | Ticker | 2025-10-29 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_3670bd7b | Expected ramp in 2026 and 2027 | 2026-01-01 | 2027-12-31 | Ramping of new Epi and ALD dipole/work-function design wins for HBM-related DRAM (ASM noted new wins that are expected to ramp in 2026–2027). | Successful 2026–2027 ramp would increase ASM's share in the DRAM/HBM market, lift equipment revenue and aftermarket services and support margin expansion; slower ramp or losses of design-wins would reduce the projected SAM gains and delay revenue/margin benefits. | Ticker | 2025-10-29 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_24a89650 | Q4 2025 bottoming; quarterly orders to pick up as 2026 progresses | 2025-10-01 | 2026-12-31 | Management's expectation that order intake will bottom in Q4 2025 at a slightly higher level than Q3 and then progressively recover through 2026. | If orders indeed bottom in Q4 and resume sequential growth in 2026, revenue visibility and investor sentiment would improve and support the company's 2026 growth outlook; if orders fail to recover, revenue guidance, backlog conversion and valuation could come under pressure. | Ticker | 2025-10-29 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_cefb159e | For 2026 (company expects China sales to decline by double digits); immediate impact from recent export restrictions | 2026-01-01 | 2026-12-31 | Normalization/decline of China demand in 2026 (management projects China sales to fall double digits in 2026) and the effect of recently announced export restrictions (management estimated a ~1–2% negative annualized sales impact). | A double-digit decline in China sales materially changes ASM's product mix and gross margin (China mix was a positive mix earlier); a steeper-than-expected China pullback or accelerated local-competitor displacement due to export controls would reduce revenue, worsen mix and could pressure margins, while a smaller decline or faster normalization would be bullish. | Theme | 2025-10-29 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_fb35a6ef | Near-term / ongoing (industry currently exempt but unclear timing of any new measures) | 2025-10-29 | 2027-10-29 | Potential new U.S. tariffs or export-control changes affecting semiconductor equipment (management said the industry is currently exempt but future tariffs remain unclear and they have contingency plans including localized U.S. manufacturing). | Implementation of tariffs or tighter export controls could raise costs, force supply-chain changes, require localized production (capex and margin consequences) and reduce sales into affected markets; absence of new tariffs or effective mitigation would limit downside. | Theme | 2025-10-29 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_996e5241 | Full year 2026 | 2026-01-01 | 2026-12-31 | Full-year 2026 gross-margin outcome vs 2025 (management explicitly noted 2026 gross margin is unlikely to improve vs 2025 given China mix and product mix uncertainty). | Gross margin trajectory in 2026 directly affects operating margin, free cash flow and the credibility of the company's 2030 margin targets; materially higher-than-expected margins would be bullish for valuation, while a material decline would be bearish. | Ticker | 2025-10-29 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_0e322051 | in 2026 | 2026-01-01 | 2026-12-31 | ASM International's actual sales growth in the China market for the full year 2026. | Management revised its outlook from a decline to an increase; actual performance will materially impact overall revenue, product mix, and gross margins, and validate the improved sentiment. | Ticker | 2026-03-03 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_f6b33119 | in 2026 | 2026-01-01 | 2026-12-31 | ASM International's reported gross margin for the full year 2026. | Achieving the guided 'higher end of the range' (46%-51%) would signal strong operational efficiency, favorable product/customer mix, and pricing power, positively impacting profitability and investor sentiment. | Ticker | 2026-03-03 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_22394c74 | starting this year in 2026 and hopefully in this year, too | 2026-01-01 | 2026-12-31 | Successful ramp of ASM's new Epi win in HBM-related DRAM and securing additional Epi design wins with other customers. | This will drive healthy growth in ASM's advanced DRAM sales, expanding its presence in the high-growth HBM market and contributing to overall revenue and market share. | Ticker | 2026-03-03 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_6e0614e8 | over '26 and '27 | 2026-01-01 | 2027-12-31 | Achievement of performance targets by Axus Technology, triggering earnout payments up to EUR 30 million. | The payment indicates successful integration and performance of the acquired CMP technology, validating the strategic rationale and potential for advanced packaging market penetration. | Ticker | 2026-03-03 | earnings_transcript | ASM.AS (ticker) |
| ONTO_8a7dbb81 | evaluations to complete in the first half of 2026 with volume ramps in the second half of 2026 | 2026-01-01 | 2026-12-31 | Customer qualification conversions and volume ramp of Onto's next-generation Dragonfly (G5) inspection systems following multiple on-site evaluations. | Bull: Successful qualification-to-volume ramps would drive substantial incremental systems revenue and market share in 2.5D/3D packaging and HBM in 2H26; Bear: prolonged evaluations or weak conversion would reduce 2H26 upside, slow revenue growth and weaken investor confidence. | Ticker | 2026-02-19 | earnings_transcript | ONTO (ticker) |
| ONTO_94754e2b | volume order conversion and production ramp in 2026 | 2026-01-01 | 2026-12-31 | Conversion of 3Di 3D/surface metrology qualifications into volume purchase orders and production-line installs for HBM4 and other advanced packaging customers. | Bull: Volume 3Di orders would add 'tens of millions' to 2026 revenue and strengthen Onto's technological moat in pre-reflow HBM metrology; Bear: delays, failed conversions or competitive displacements would materially reduce expected packaging revenue and valuation upside. | Ticker | 2026-02-19 | earnings_transcript | ONTO (ticker) |
| ONTO_b3d6adf5 | second quarter 2026 (management expects revenue exceeding $300 million) | 2026-04-01 | 2026-06-30 | Reported Q2 2026 revenue exceeding $300 million as a check on accelerating demand and backlog conversion. | Bull: Q2 >$300M would confirm the accelerating top-line trajectory and underpin management's 12–14% H1 core growth claim; Bear: failure to reach this milestone would indicate slower conversion of evaluations/backlog and reduce 2026 upside. | Ticker | 2026-02-19 | earnings_transcript | ONTO (ticker) |
| ONTO_84ad653d | first quarter 2026 (first full quarter contribution) and full-year 2026 integration outcomes | 2026-01-01 | 2026-12-31 | Realized revenue, margin and cross-sell contribution from the Semilab acquisition (first full quarter of contribution in Q1 2026; management cited ~$100–110M potential revenue for Semilab in 2026). | Bull: Semilab meeting or exceeding revenue and integration targets would be accretive to 2026 revenue and margins and de-risk the expanded TAM claim; Bear: integration issues or weaker-than-expected Semilab sales (e.g., power semi weakness) would reduce expected accretion and margin expansion. | Ticker | 2026-02-19 | earnings_transcript | ONTO (ticker) |
| ONTO_eb4c53a7 | over the first half of 2026 (management noted supplier strain and gradual extension of lead times) | 2026-01-01 | 2026-06-30 | Potential supplier lead-time extensions (notably precision optics and other fixed-lead-time components) that could delay tool deliveries and constrain ability to meet customer pull-ins. | Extended lead times could bottleneck shipments and defer revenue recognition, reducing near-term growth and pressuring margins; effective supplier management would preserve the guided ramp and revenue cadence. | Ticker | 2026-02-19 | earnings_transcript | ONTO (ticker) |
| ONTO_f51020af | 2026 (timing hinges on how quickly new cleanroom space becomes available) | 2026-01-01 | 2026-12-31 | Industry-level availability and timing of new cleanroom/fab capacity expansions (TSMC and hyperscaler factory builds) that determine how quickly WFE and advanced-packaging demand can absorb new tools. | Theme-level: Faster completion of cleanroom/fab capacity would accelerate WFE and packaging tool orders (bull), while delays would cap 2026 WFE growth forecasts and reduce demand visibility for Onto and peers (bear). | Theme | 2026-02-19 | earnings_transcript | ONTO (ticker) |
| ASM.AS_c570d343 | In the second half of 2026 (pilot) with volume production in 2027–2028 | 2026-07-01 | 2028-12-31 | Start of 1.4-nanometer pilot-line tool orders in H2 2026 and subsequent ramp to high-volume manufacturing in 2027–2028 (ASM expects first pilot investments in H2 2026). | If pilot orders materialize and HVM ramps on schedule, ASM could capture the stated SAM uplift ($450–500M) and drive meaningful equipment revenue and higher-margin ALD/Epi sales; delays, fewer customers, or slower HVM would reduce near-term revenue/margin upside and delay 2027–2028 growth. | Ticker | 2025-10-29 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_9dacb8d8 | second half of 2026 | 2026-07-01 | 2026-12-31 | Start of pilot line investments for the 1.4 nanometer node by customers, with potential for multiple customer commitments. | This milestone indicates the pace of advanced node adoption and ASM's ability to capture significant served available market expansion, driving future revenue and market share. Bullish if multiple customers commit. | Ticker | 2026-03-03 | earnings_transcript | ASM.AS (ticker) |
| ASM.AS_2f4db00d | first quarter of 2027 | 2027-01-01 | 2027-03-31 | Completion of the new Scottsdale facility, enabling substantial expansion of ALD and Epi product development activity. | This expansion is crucial for ASM's innovation pipeline, supporting the development of next-generation technologies and securing future design wins and market leadership. | Ticker | 2026-03-03 | earnings_transcript | ASM.AS (ticker) |